Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LL...

FDA Drug Recall #D-1094-2023 — Class III — August 10, 2023

Recall Summary

Recall Number D-1094-2023
Classification Class III — Low risk
Date Initiated August 10, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Imprimis NJOF, LLC
Location Ledgewood, NJ
Product Type Drugs
Quantity 2,683 bottles

Product Description

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

Reason for Recall

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

Distribution Pattern

Nationwide in the US

Lot / Code Information

Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.

Other Recalls from Imprimis NJOF, LLC

Recall # Classification Product Date
D-0250-2026 Class II Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL... Dec 18, 2025
D-0249-2026 Class II Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/... Dec 18, 2025
D-0251-2026 Class II Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxa... Dec 18, 2025
D-0157-2026 Class III Klarity-C Drops (Cyclosporine) 0.1%, Preservati... Oct 20, 2025
D-0535-2025 Class II Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg... Jul 9, 2025

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.